Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Study Summary

Previous related pageVitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence ReviewNext related pageVitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review
Study at a glance

What was studied?

This review compares human B-cell experiments, lupus immune-cell measurements and vaccine studies. B cells produce antibodies, proteins that recognise particular targets, and can contribute to responses when a target appears again. The studies tested active hormone, vitamin D3 or calcifediol, a circulating form requiring activation.

What was found?

Active hormone could increase antibody-secreting cells under one laboratory protocol. Some blood memory B-cell measurements fell in a small study of lupus, an autoimmune disease involving reactions against the body’s own material, without an untreated comparison. The elderly influenza trial and larger CORONAVIT vaccine analysis did not establish an overall benefit. Smaller positive vaccine reports had important problems with group assignment, follow-up or reporting.

What does it mean?

Changes in cell proteins, antibody signals or memory-associated genes are not the same as lasting protection against infection. Lower memory-cell measurements during autoimmune disease do not prove stronger protective memory.

What are the limits?

The studies measured different outcomes. A later study of genes used people from the earlier study, so it was not independent confirmation. Long-lived protective memory remains uncertain. The forms and amounts tested do not establish a personal supplement regimen.

Read the full article below ↓

Vitamin D can change B-cell activity, but the reviewed studies do not establish stronger lasting immune memory. Laboratory experiments, lupus immune-cell measurements and vaccine trials tested different outcomes. Larger randomized vaccine evidence did not show a consistent benefit. Some smaller reports were positive but had important limitations. The detailed counterpart is Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review.

What was studied?

B cells produce antibodies, which recognise particular targets. Some B cells help respond when a target appears again. T cells also contribute to memory. An antibody change today does not by itself show protection months or years later. This distinction is central to Vitamin D and Immune Memory.

The review compared human B-cell experiments, a small lupus intervention, an elderly influenza-vaccine trial and the CORONAVIT vaccine studies. Smaller positive COVID-19 vaccine reports were also assessed. Four central studies do not mean four direct trials of long-lived memory formation.

What happened in B-cell experiments?

Treptow grew human naive B cells, which have not yet responded to their particular target. Under specific activating signals, calcitriol, the active vitamin D hormone, could increase antibody-secreting cells and immunoglobulin A, a type of antibody. A vitamin-A-related compound was also tested, so combined effects cannot all be assigned to vitamin D. [1]

The experiment lasted about seven days. It did not show lasting protection, fewer infections or long-lived antibody-producing cells in people. Direct active-hormone exposure differs from taking vitamin D3 by mouth.

Lupus is an autoimmune disease, in which immunity reacts against the body’s own material. In twenty women with relatively inactive lupus, some blood memory B-cell measurements fell during supplementation. There was no untreated comparison group. The measurements did not identify every memory cell as directed against the body. They did not show better protective memory against infection, and disease activity did not clearly improve. [2]

Vitamin D and Immune Tolerance explains why restraining inappropriate responses differs from increasing protective memory.

What did the stronger vaccine comparisons find?

The influenza trial analysed thirty-eight older adults, nineteen per group. Assignment was by chance. One group received placebo, a comparison without vitamin D. Vitamin D status increased, but overall vaccine antibody responses did not improve. Some results for particular influenza-virus types favoured placebo. There were too few participants to reliably detect some effects, and responses were assessed only twenty-eight days after vaccination. The trial did not prove universal harm or no possible benefit. [3]

CORONAVIT did not establish fewer infections after vaccination or clear improvements in tested antibody and cellular responses. Different groups supplied different measurements within one parent trial. They were not independent trials. Controls had no measured vitamin D concentration at the start. Analyses excluded people who reported taking assigned capsules less than half the time and controls who reported any vitamin D supplement use. These exclusions limit how fully chance assignment protects the comparison. Follow-up did not establish years of protection. [4]

Why do positive reports need caution?

Bhat’s programme tested calcifediol, the circulating precursor that cells can convert to active hormone. It reported more cell division after cells encountered virus-related material in a laboratory test, and fewer probable COVID-19 illnesses. Participants chose treatment or placebo, so other group differences could affect results. Follow-up was incomplete, and probable illness was not always confirmed by an infection test. [5]

A later twenty-four-person gene study used people from that programme. It was not independent confirmation. Changes in memory-associated genes did not prove functional long-lived memory or fewer infections. [8]

Cesur’s small study reported a higher antibody signal at four weeks, but no significant difference between groups at eight weeks. Assignment was not clearly explained, groups differed at the start and dose descriptions disagreed. Fateh’s positive report had differing participant totals, important group differences and an antibody test that was not clearly described. Neither demonstrated lasting memory or clinical protection. [6] [7]

What does this mean?

Vitamin D and Immune Modulation explains response regulation; this does not mean increasing every response. Older-adult vaccine findings relate to Vitamin D and Immune Ageing but do not show reversal of age-related immune change.

Vitamin D can affect some B-cell functions, while lasting protective benefit remains uncertain. The forms and amounts tested differ and do not establish a personal regimen for improving vaccine memory.

Primary sources

[1] Treptow S et al. 9-cis Retinoic acid and 1.25-dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells. European journal of immunology. 2021;51(1):125-137. DOI: 10.1002/eji.202048557. PMID: 33107588.

[2] Terrier B et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis research & therapy. 2012;14(5):R221. DOI: 10.1186/ar4060. PMID: 23075451.

[3] Goncalves-Mendes N et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in immunology. 2019;10:65. DOI: 10.3389/fimmu.2019.00065. PMID: 30800121.

[4] Jolliffe DA et al. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 2022;14(18):3821. DOI: 10.3390/nu14183821. PMID: 36145196.

[5] Bhat S et al. Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial. The Journal of infection. 2023;86(5):e120-e122. DOI: 10.1016/j.jinf.2023.03.004. PMID: 36889512.

[6] Cesur F et al. Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial. Vaccine. 2023;41(17):2860-2867. DOI: 10.1016/j.vaccine.2023.03.046. PMID: 37003908.

[7] Fateh HL et al. The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial. Clinical nutrition research. 2023;12(4):269-282. DOI: 10.7762/cnr.2023.12.4.269. PMID: 37969936.

[8] Saroha HS et al. Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses. NPJ vaccines. 2024;9(1):114. DOI: 10.1038/s41541-024-00909-w. PMID: 38902265.

Related reading

Physiology

Vitamin D and Immune Memory

Explains how vitamin D relates to immune memory, T and B cells, cytokine signalling, antigen presentation, immune ageing, and long-term immune readiness.

Read more →
Library

The Expressions of the Immunity: and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the In Ovo and Dietary Supplemental Administration of Calcidiol in Conjunction with the In Ovo Administration of Marek’s Disease Vaccine †

The purpose of the current study was to identify the impacts of supplemental 25(OH)D3 administered dietarily or by in ovo injection in conjunction with the in ovo delivery of Marek’s Disease vaccine (MVD), on the expression of genes in the spleen and pectoralis major (P.

Original paper ↗Read more →

Original sources

Source

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

In this prospective study, we evaluated the safety and the immunological effects of vitamin D supplementation (100 000 IU of cholecalciferol per week for 4 weeks, followed by 100 000 IU of cholecalciferol per month for 6 months.) in 20 SLE patients with hypovitaminosis D.

Publication details

[2] Terrier B et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis research & therapy. 2012;14(5):R221. DOI: 10.1186/ar4060. PMID: 23075451.

Read more →
Source

Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial

This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.

Publication details

[3] Goncalves-Mendes N et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in immunology. 2019;10:65. DOI: 10.3389/fimmu.2019.00065. PMID: 30800121.

Read more →
Source

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial

Sub-study 1 (n = 2808) investigated the effects of vitamin D supplementation on the risk of breakthrough SARS-CoV-2 infection following two doses of SARS-CoV-2 vaccine.

Publication details

[4] Jolliffe DA et al. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 2022;14(18):3821. DOI: 10.3390/nu14183821. PMID: 36145196.

Read more →
Source

Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial

Published in The Journal of infection (2023).

Publication details

[5] Bhat S et al. Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial. The Journal of infection. 2023;86(5):e120-e122. DOI: 10.1016/j.jinf.2023.03.004. PMID: 36889512.

Read more →
Source

The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial

Published in Clinical nutrition research (2023).

Publication details

[7] Fateh HL et al. The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial. Clinical nutrition research. 2023;12(4):269-282. DOI: 10.7762/cnr.2023.12.4.269. PMID: 37969936.

Read more →
Source

Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses

In our previous study eligible subjects were supplemented with calcifediol, a direct precursor to the biologically active form of vitamin D, calcitriol with an objective to enhance the immunogenicity of the COVISHIELD vaccine.

Publication details

[8] Saroha HS et al. Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses. NPJ vaccines. 2024;9(1):114. DOI: 10.1038/s41541-024-00909-w. PMID: 38902265.

Read more →